PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35288472-5	2022	Whereas S-specific CD4 and CD8 T cell responses were largely compromised by fingolimod treatment, T cell responses were robustly generated in anti-CD20-treated MS patients, but with a reduced proportion of CD4+CXCR5+ circulating follicular Th cells.	Fingolimod Hydrochloride	76-86	C-X-C motif chemokine receptor 5	Homo sapiens	210-215	
32034063-7	2020	The circulating T follicular regulatory cell subset and CXCR5+ CD8+ T cell frequencies were also strongly and disproportionally decreased after fingolimod treatment.	Fingolimod Hydrochloride	144-154	C-X-C motif chemokine receptor 5	Homo sapiens	56-61